Clinical Trial

Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain

Name: Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain — clinical trial record (NCT07318688)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A phase 3 study to evaluate the efficacy and safety of HMI-115 in women with moderate to severe endometriosis-associated pain over a 24-week treatment period and a 28-week extension

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-12

Trial Details

NCT Number	NCT07318688
Lead Sponsor	Hope Medicine (Nanjing) Co., Ltd
Conditions	Endometriosis
Enrollment	540 participants
Start Date	2026-01-29
Primary Completion	2028-03-01 (estimated)
Study Completion	2028-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-11